The cost-effectiveness of a family meetings intervention to prevent depression and anxiety in family caregivers of patients with dementia: a randomized trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The cost-effectiveness of a family meetings intervention to prevent depression and anxiety in family caregivers of patients with dementia: a randomized trial ; volume:14 ; number:1 ; day:22 ; month:9 ; year:2013 ; pages:1-13 ; date:12.2013
Trials ; 14, Heft 1 (22.9.2013), 1-13, 12.2013
- Creator
-
Joling, Karlijn J.
- Contributor
-
Bosmans, Judith E.
van Marwijk, Harm W J.
van der Horst, Henriëtte E.
Scheltens, Philip
Vroomen, Janet L MacNeil
van Hout, Hein P J.
SpringerLink (Online service)
- DOI
-
10.1186/1745-6215-14-305
- URN
-
urn:nbn:de:1111-2016050230594
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Joling, Karlijn J.
- Bosmans, Judith E.
- van Marwijk, Harm W J.
- van der Horst, Henriëtte E.
- Scheltens, Philip
- Vroomen, Janet L MacNeil
- van Hout, Hein P J.
- SpringerLink (Online service)
Other Objects (12)
(Cost)-effectiveness of family meetings on indicated prevention of anxiety and depressive symptoms and disorders of primary family caregivers of patients with dementia: design of a randomized controlled trial
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial
The “rights” of precision drug development for Alzheimer’s disease
Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
Profile of family caregivers of elderly at home
(Cost)-effectiveness of family meetings on indicated prevention of anxiety and depressive symptoms and disorders of primary family caregivers of patients with dementia: design of a randomized controlled trial
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial
The “rights” of precision drug development for Alzheimer’s disease
Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
Profile of family caregivers of elderly at home
(Cost)-effectiveness of family meetings on indicated prevention of anxiety and depressive symptoms and disorders of primary family caregivers of patients with dementia: design of a randomized controlled trial
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial
The “rights” of precision drug development for Alzheimer’s disease
Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks
Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies